SCHEMBL24355247

SCHEMBL24355247

Nc1ccc([C@@H](O)C=O)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
GRM8 O00222 1/20 0.38
GRM7 Q14831 1/20 0.38
GRM4 Q14833 1/20 0.38
ALDH1A1 P00352 3/20 0.36
CYP3A4 P08684 3/20 0.36
ALOX15 P16050 2/20 0.36
CA3 P07451 1/20 0.36
THRB P10828 1/20 0.36
CA6 P23280 1/20 0.36
CASP1 P29466 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
CA14 Q9ULX7 1/20 0.36
TSHR P16473 4/20 0.34
RAB9A P51151 2/20 0.34
KDM4E B2RXH2 1/20 0.34
NT5E P21589 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24355252 1.00 MAPT (0.38) MAPTMEN1KMT2AGRM8GRM7
SCHEMBL15018764 0.78 ESR1 (0.44) MAPTMEN1KMT2AALDH1A1CYP3A4
SCHEMBL1162469 0.76 TSHR (0.53) CYP3A4ALOX15HIF1AHSD17B10TSHR
SCHEMBL2356074 0.76 CYP2A6 (0.42) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL15833075 0.76 HDAC3 (0.42) ALDH1A1SMN1; SMN2LMNA
SCHEMBL6404428 0.76 MAPT (0.38) MAPTMEN1KMT2AGRM8GRM7
SCHEMBL1712779 0.76 HDAC3 (0.42) ALDH1A1SMN1; SMN2LMNA
SCHEMBL28839965 0.76 CYP1A2 (0.42) MEN1KMT2AALOX15SMN1; SMN2CNR1
SCHEMBL21436893 0.76 CYP1A2 (0.42) MEN1KMT2AALOX15SMN1; SMN2CNR1
SCHEMBL3793092 0.76 TPMT (0.36) ALOX15TSHRAPEX1CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220127297-A1 Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics AGILEBIOTICS B.V. (NL) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127297-A1 Novel Antibacterial 3\"-Derivatives Of 4,6-Disubstituted 2,5-Dideoxystreptamine Aminoglycoside Antibiotics ABCC1, AMPD3, MRPS35 MAPT 3033/4885MEN1 4383/4885KMT2A 3497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.